BDBM200931 (−)-4,6-dimethyl-5-[2-methyl-4-(1,7-naphthyridin-8-yloxy)phenyl]pyridazin-3(2H)-one::US9540352, example 3

SMILES: Cc1cc(Oc2nccc3cccnc23)ccc1-c1c(C)n[nH]c(=O)c1C

InChI Key: InChIKey=OOTAIOGBMSGKTK-UHFFFAOYSA-N

Data: 1 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 200931   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
D(1A) dopamine receptor (Homo sapiens (Human))	BDBM200931 ((−)-4,6-dimethyl-5-[2-methyl-4-(1,7-naphthyr...) Show SMILES Cc1cc(Oc2nccc3cccnc23)ccc1-c1c(C)n[nH]c(=O)c1C |(10.67,1.54,;9.34,2.31,;8,1.54,;6.67,2.31,;5.33,1.54,;5.33,,;6.67,-.77,;6.67,-2.31,;5.33,-3.08,;4,-2.31,;2.67,-3.08,;1.33,-2.31,;1.33,-.77,;2.67,,;4,-.77,;6.67,3.85,;8,4.62,;9.34,3.85,;10.67,4.62,;10.67,6.16,;9.34,6.93,;12,6.93,;13.34,6.16,;13.34,4.62,;14.67,3.85,;12,3.85,;12,2.31,)| Show InChI InChI=1S/C21H18N4O2/c1-12-11-16(27-21-19-15(8-10-23-21)5-4-9-22-19)6-7-17(12)18-13(2)20(26)25-24-14(18)3/h4-11H,1-3H3,(H,25,26)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	102	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Dif...				US Patent US9540352 (2017) BindingDB Entry DOI: 10.7270/Q2X34VND
					More data for this Ligand-Target Pair